Showing results (61-70 of 119) with videos related to
Sort By:
Pageof 12
The Oncologist|April 1, 2014
Randomized phase II trial comparing carboplatin plus weekly paclitaxel and docetaxel alone in elderly patients with advanced non-small cell lung cancer: north japan lung cancer group trial 0801Makoto Maemondo, Akira Inoue, Shunichi Sugawara, et al.Investigational New Drugs|February 3, 2017
A phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016)Satoru Miura, Makoto Maemondo, Akira Iwashima, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated <i>EGFR</i>Eisaku Miyauchi, Satoshi Morita, Atsushi Nakamura, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2019
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 StudyYukio Hosomi, Satoshi Morita, Shunichi Sugawara, et al.Scientific Reports|February 20, 2025
Prevalence of erectile dysfunction as long-COVID symptom in hospitalized Japanese patientsHideaki Kato, Nao Ichihara, Hiroki Saito, et al.Oncology|October 5, 2011
Phase II study of irinotecan plus S-1 combination for previously untreated advanced non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601Kenji Akie, Satoshi Oizumi, Shigeaki Ogura, et al.Journal of Clinical Microbiology|August 24, 2012
Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseasesToshiyuki Harada, Yasushi Akiyama, Atsuyuki Kurashima, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2020
A Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial PneumonitisSatoshi Ikeda, Terufumi Kato, Hirotsugu Kenmotsu, et al.Translational Lung Cancer Research|July 18, 2020
Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323Toshiyuki Kozuki, Naoyuki Nogami, Osamu Hataji, et al.Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naïve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901Naoto Morikawa, Akira Inoue, Shunichi Sugawara, et al.Pageof 12